Follow
Segev Shani
Segev Shani
Senior Adjunct lecturer, Health Systems Management Department, Ben Gurion University
Verified email at bgu.ac.il
Title
Cited by
Cited by
Year
The anticariogenic effect of amine fluorides on Streptococcus sobrinus and glucosyltransferase in biofilms
S Shani, M Friedman, D Steinberg
Caries research 34 (3), 260-267, 2000
1472000
Setting priorities for the adoption of health technologies on a national level—the Israeli experience
S Shani, MI Siebzehner, O Luxenburg, J Shemer
Health Policy 54 (3), 169-185, 2000
1012000
Relation between surface activity and antibacterial activity of amine-fluorides
S Shani, M Friedman, D Steinberg
International journal of pharmaceutics 131 (1), 33-39, 1996
361996
Developing and implementing a model for changing physicians’ prescribing habits–the role of clinical pharmacy in leading the change
E Schwartzberg, S Rubinovich, D Hassin, J Haspel, A Ben‐Moshe, ...
Journal of clinical pharmacy and therapeutics 31 (2), 179-185, 2006
292006
In vitro assessment of the antimicrobial activity of a local sustained release device containing amine fluoride for the treatment of oral infectious diseases
S Shani, M Friedman, D Steinberg
Diagnostic microbiology and infectious disease 30 (2), 93-97, 1998
221998
Cost-benefit analysis of risperidone and clozapine in the treatment of schizophrenia in Israel
G Ginsberg, S Shani, B Lev
Pharmacoeconomics 13 (2), 231-241, 1998
171998
Regulation of natural medicines in Israel and abroad
T Lavy, B Haran, J Shemer, S Shani
Harefuah 139 (9-10), 339-44, 408, 407, 2000
112000
The Israeli model for managing the national list of health services in an era of limited resources
S Shani, Z Yahalom
Law & Policy 24 (2), 133-147, 2002
102002
Adverse drug reactions definitions and terminology
H Rabinovitz, M Berkowitch, A Golik, S Shani
Harefuah 140 (12), 1181-6, 1228, 2001
102001
Promoting medical technologies in the national list of health services: 1995-2000
J Shemer, T Morginstin, A Hammerman, O Luxenburg, S Shani
Harefuah 142 (2), 82-86, 2003
72003
Patients' perceptions of drug therapy counseling in Israel.
S Shani, T Morginstin, A Hoffman
The Israel Medical Association journal: IMAJ 2 (6), 438-441, 2000
62000
The Role of the Pharmaceutical Industry in Disseminating Pharmacovigilance Practice in Developing Countries
S Shani, Z Yahalom
Food & Drug LJ 63, 701, 2008
52008
Role of the pharmacist in a modern health care system
S Shani, J Shemer
Harefuah 138 (4), 327, 2000
52000
Evaluation of the impact of a clinical pharmacist on the quality and cost of pharmacotherapy in a general surgical department, the Hillel-Yaffe Medical Center
E Schwartzberg, S Livny, A Sterenberg, A Troitsa, M Oren, S Shani
Harefuah 142 (1), 5-9, 80, 2003
42003
Israel hospital pharmaceutical services: a national survey
S Livny, A Hammerman, S Shani, J Shemer
Harefuah 138 (10), 828-31, 911, 910, 2000
42000
Legal and regulatory aspects of orphan drugs.
S Shani, Z Yahalom
Pediatric endocrinology reviews: PER 11, 110-115, 2013
32013
The influence of the relationship between physicians and pharmaceutical companies on the patient from the point of view of policy-makers in Israel
R Nissanholtz-Gannot, S Shani, S Shvarts
Harefuah 149 (11), 688-92, 750, 2010
32010
Herceptin
T Morginstin, S Shani, J Shemer
Harefuah 138 (6), 459, 2000
32000
Evaluation of amine fluoride-bacteria interactions on an experimental dental plaque model
S Shani, M Friedman, D Steinberg
JOURNAL OF DENTAL RESEARCH 75, 1879-1879, 1996
31996
Prescribing information for drugs--legal and regulatory implications
Z Yahalom, S Shani
Harefuah 153 (11), 671-4, 686, 2014
22014
The system can't perform the operation now. Try again later.
Articles 1–20